New York City-based Colgate-Palmolive Co. (CL) is a global consumer products company with a distribution network reaching more than 200 countries. The company has a stellar long-term growth record. Positive earning surprises along with savings from the company's restructuring and business-building plan should support future growth.
The company remains the clear market leader in the oral care segment. With an array of new products launched in 2008, Colgate-Palmolive is delivering strong results despite aggressive advertising expenditures and higher input costs. Its tight financial controls and efforts to enhance shareholder value through share repurchases and dividend increases support a positive long-term view on the stock.
The stock is rated a Buy with a target price of $79.50, based on a 21 P/E on 12 month trailing earnings.
Read the full analyst report on CL
Get real-time market insights and profitable stock recommendations from the team of analysts at Zacks Equity Research. See all todays Analyst Blog entries on Zacks.com.